BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35644005)

  • 1. Duality of bone morphogenetic proteins in cancer: A comprehensive analysis.
    Sharma T; Kapoor A; Mandal CC
    J Cell Physiol; 2022 Aug; 237(8):3127-3163. PubMed ID: 35644005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
    Jiramongkolchai P; Owens P; Hong CC
    Biochem Soc Trans; 2016 Aug; 44(4):1117-34. PubMed ID: 27528760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
    Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
    Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of BMP Signaling and NF-κB Signaling on Osteoblastic Differentiation, Cancer Development, and Vascular Diseases--Is the Activation of NF-κB a Friend or Foe of BMP Function?
    Jimi E
    Vitam Horm; 2015; 99():145-70. PubMed ID: 26279375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP Signaling Pathway in Dentin Development and Diseases.
    Liu M; Goldman G; MacDougall M; Chen S
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells.
    Graham TR; Odero-Marah VA; Chung LW; Agrawal KC; Davis R; Abdel-Mageed AB
    Prostate; 2009 Feb; 69(2):168-80. PubMed ID: 18942118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?
    Ehata S; Yokoyama Y; Takahashi K; Miyazono K
    Pathol Int; 2013 Jun; 63(6):287-96. PubMed ID: 23782330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaB-independent bone morphogenetic protein/Smad signaling.
    Chen S; Guttridge DC; Tang E; Shi S; Guan K; Wang CY
    J Biol Chem; 2001 Oct; 276(42):39259-63. PubMed ID: 11500509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factors-Intricate players of the bone morphogenetic protein signaling pathway.
    Ampuja M; Kallioniemi A
    Genes Chromosomes Cancer; 2018 Jan; 57(1):3-11. PubMed ID: 28857319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP and UTP stimulate bone morphogenetic protein-2,-4 and -5 gene expression and mineralization by rat primary osteoblasts involving PI3K/AKT pathway.
    Ayala-Peña VB; Scolaro LA; Santillán GE
    Exp Cell Res; 2013 Aug; 319(13):2028-2036. PubMed ID: 23707969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversy of physiological vs. pharmacological effects of BMP signaling: Constitutive activation of BMP type IA receptor-dependent signaling in osteoblast lineage enhances bone formation and resorption, not affecting net bone mass.
    Kamiya N; Atsawasuwan P; Joiner DM; Waldorff EI; Goldstein S; Yamauchi M; Mishina Y
    Bone; 2020 Sep; 138():115513. PubMed ID: 32603910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular BMP Antagonists, Multifaceted Orchestrators in the Tumor and Its Microenvironment.
    Ouahoud S; Hardwick JCH; Hawinkels LJAC
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein receptor signal transduction in human disease.
    Gomez-Puerto MC; Iyengar PV; García de Vinuesa A; Ten Dijke P; Sanchez-Duffhues G
    J Pathol; 2019 Jan; 247(1):9-20. PubMed ID: 30246251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic proteins and cancer: review of the literature.
    Thawani JP; Wang AC; Than KD; Lin CY; La Marca F; Park P
    Neurosurgery; 2010 Feb; 66(2):233-46; discussion 246. PubMed ID: 20042986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism for the action of bone morphogenetic proteins and regulation of their activity.
    Ebara S; Nakayama K
    Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S10-5. PubMed ID: 12205413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling.
    Peng Y; Kang Q; Cheng H; Li X; Sun MH; Jiang W; Luu HH; Park JY; Haydon RC; He TC
    J Cell Biochem; 2003 Dec; 90(6):1149-65. PubMed ID: 14635189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a novel class of benzimidazoles as highly effective agonists of bone morphogenetic protein (BMP) receptor signaling.
    Najafi S; Barasa L; Huang SY; Yoganathan S; Perron JC
    Sci Rep; 2022 Jul; 12(1):12146. PubMed ID: 35840622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.
    Carreira AC; Zambuzzi WF; Rossi MC; Astorino Filho R; Sogayar MC; Granjeiro JM
    Vitam Horm; 2015; 99():293-322. PubMed ID: 26279381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of bone morphogenetic proteins in cancer.
    Davis H; Raja E; Miyazono K; Tsubakihara Y; Moustakas A
    Cytokine Growth Factor Rev; 2016 Feb; 27():81-92. PubMed ID: 26678814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.